Knowlton
TL3 Regular · Szeged, HU
Clinician. Posts general information only, and says so every time.
Joined 27 October 2024 · last posted 2d · groups: clinicians
144Posts here
2Topics
1Solutions
995Likes received
978Likes given
27Badges
304Days visited
4.7kPosts read
Most-liked posts
-
Reading a trial's population section before its results — does this still hold? Replied, post #33 · Evidence › Trials · 23 Apr 2025 · 33 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
SNAC and the mechanism of oral peptide absorption — the long version Replied, post #11 · Compounds › Oral incretins · 16 Nov 2024 · 33 likes Adding a data point of agreement rather than a data point.
-
What I would want from a home test that does not exist yet — what changed since Replied, post #37 · Analytics › Home & field testing · 30 May 2026 · 32 likes Research-use-only material is not certified for anything by anybody, and no home procedure changes that. What home checks buy you is early detection of the obvious…
-
Coverage for the indication versus for the drug — a second dataset Replied, post #3 · Access › Insurance & coverage · 5 Mar 2025 · 32 likes I disagree with the framing of Coverage above, and I think it is a substantive disagreement rather than a terminological one. Setting out why, so it can be checked. The…
-
What changed in 2026, by region Replied, post #116 · Access › International · 2 Feb 2025 · 32 likes Country-by-country legality: compound approval and legal status differ substantially by jurisdiction. Semaglutide approved in the United States and European Union;…
-
The mass-error checker and its intended scope Replied, post #9 · Data & Tools › Calculators · 23 May 2024 · 32 likes I would be cautious about generalising from the mass-error checker example above. It is a good example. It is one example.
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Read the Guidelines | bronze | 28 Oct 2024 |
| Basic User | bronze | 30 Oct 2024 |
| First Topic | bronze | 30 Oct 2024 |
| First Reply | bronze | 2 Nov 2024 |
| Welcome | bronze | 15 Nov 2024 |
| First Solution | bronze | 23 Nov 2024 |
| First Link | bronze | 24 Nov 2024 |
| Member | bronze | 25 Nov 2024 |
| First Quote | bronze | 2 Dec 2024 |
| Sourced | bronze | 3 Dec 2024 |
| First Tag | bronze | 22 Dec 2024 |
| Generous | bronze | 22 Jan 2025 |
| Consistently Generous | silver | 23 Jan 2025 |
| Reader | bronze | 28 Jan 2025 |
| First Vendor Report | bronze | 5 Feb 2025 |
| Good Topic | silver | 6 Feb 2025 |
| Regular | silver | 17 Feb 2025 |
| Good Post | silver | 20 Feb 2025 |
| Editor | bronze | 14 Mar 2025 |
| Nice Topic | bronze | 28 Mar 2025 |
| Nice Post | bronze | 30 Mar 2025 |
| Welcoming | silver | 3 Apr 2025 |
| Thank You | silver | 18 May 2025 |
| Popular Link | silver | 3 Jul 2025 |
| Well Sourced | silver | 13 Jul 2025 |
| Anniversary | silver | 27 Oct 2025 |
| Changed My Mind | silver | 5 Dec 2025 |